Sarepta Therapeutics buy BiotechBee
Start price
29.10.23
/
50%
€15.21
Target price
31.03.26
€150.00
Performance (%)
-
End price
30.10.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sarepta Therapeutics | 8.527% | 8.527% | -84.055% |
| iShares Core DAX® | -3,52 % | -4,99 % | 1,93 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % | 15,43 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % | 29,01 % |
| iShares S&P 500 | -0,82 % | -0,04 % | 10,81 % |
According to BiotechBee what are the pros and cons of Sarepta Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year